LAVA Therapeutics N.V. (LVTX)
0.97
-0.01 (-1.02%)
At close: Jan 15, 2025, 3:57 PM
0.96
-1.03%
After-hours Jan 15, 2025, 05:20 PM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| PE Ratio | -1.01 | -2.84 | -2.57 | -22.76 | -27.18 |
| PS Ratio | 6.24 | 4.68 | 20.31 | 96.75 | n/a |
| PB Ratio | 0.83 | 1.05 | 0.81 | 38.72 | 39.71 |
| P/FCF Ratio | -1.06 | 26.25 | -3.26 | -27.01 | -24.75 |
| P/OCF Ratio | -1.08 | 22.44 | -3.35 | -28.4 | -26.94 |
| OCF/S Ratio | -5.76 | 0.21 | -6.07 | -3.41 | n/a |
| Debt / Equity Ratio | 0.12 | 0.06 | 0.04 | 0.54 | 0.30 |
| Quick Ratio | 6.62 | 6.40 | 40.52 | 2.43 | 5.35 |
| Current Ratio | 6.62 | 6.40 | 30.80 | 2.54 | 5.35 |
| Asset Turnover | 0.07 | 0.14 | 0.03 | 0.15 | n/a |
| Interest Coverage | n/a | n/a | -69.78 | -42.9 | n/a |
| Return on Equity (ROE) | -0.82 | -0.37 | -0.32 | -1.7 | -1.46 |
| Return on Assets (ROA) | -0.41 | -0.22 | -0.27 | -0.63 | -0.97 |
| Return on Capital (ROIC) | -0.5 | -0.29 | -0.29 | -0.9 | -1.15 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 48.56% | 100.00% | 100.00% | -319.03% | n/a |
| Net Profit Margin | -620.09% | -164.55% | -791.68% | -425.06% | n/a |
| Pretax Profit Margin | -615.97% | -163.26% | -788.75% | -423.91% | n/a |
| Operating Profit Margin | -638.99% | -179.66% | -815.2% | -391.59% | n/a |
| FCF Margin | -586.53% | 17.82% | -623.24% | -358.27% | n/a |
| EBITDA Margin | -597.09% | -159.23% | -766.64% | -391.04% | n/a |